Testing drugs on virtual tumors first: symbolic AI retrospectively predicts breast cancer response, with 74% agreement across 31 cases
Researchers used patients’ genetic data to build tumor “digital twins,” reproducing existing treatment responses and identifying potential drug options for those with incomplete responses. However, the improvements predicted by computer simulations still require validation in prospective clinical studies.